Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
fda
6
×
life sciences
national blog main
clinical trials
boston top stories
cancer
san francisco blog main
europe blog main
ipo
new york blog main
new york top stories
san diego blog main
san diego top stories
akouos
biogen
boston
boulder/denver blog main
boulder/denver top stories
cancer drugs
deals
deerfield management
detroit blog main
detroit top stories
drug discovery
europe top stories
gilead sciences
indiana blog main
indiana top stories
investing
melinta therapeutics
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
sanofi
seattle blog main
What
ipo
6
×
medicines
6
×
developing
drug
therapeutics
bio
covid
fda
new
plans
roundup
acquisitions
activity
affects
americans
announced
approvals
approved
biogen
biotech
black
brings
cancer
ceo
clamped
clinic
collabs
companies
company
company’s
course
daniel
date
deal
delays
development
diamond
discover
disorders
dyne
Language
unset
Current search:
ipo
×
fda
×
medicines
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds